Breast Biopsy Device Market Analysis By Test Type (Needle Breast Biopsy: Fine-Needle Aspiration, Core-Needle Biopsy, Vacuum-Assisted Core Biopsy; Open Surgical Biopsy: Incisional Breast Biopsy), By Product (Biopsy Needles, Biopsy Tables, Localization Wires, Guidance Systems), By Guidance Type (Ultrasound-Guided, Mammography-Guided Stereotactic, Magnetic Resonance-Guided), By Region (U.S., Canada, Germany, UK, China, India, Brazil, Mexico, South Africa) And Segment Forecasts To 2024
The breast biopsy device market is expected to reach USD 911.2 million by 2024, according to a new report by Grand View Research, Inc. The Breast biopsy device market is projected to grow at a productive rate in the next few years. The key factors supporting the industry’s growth involve the rising awareness levels with regard to diagnostic procedures through cancer screening programs, global rise in breast cancers in women, and the high demand for less-invasive procedures. However, the degree of risk is directly proportional to the extent of procedure invasiveness. Biopsy causes pain and is a stressful procedure for patients, moreover, approximately 60% to 80% of breast biopsies in women result in a benign judgment. Therefore, women are encouraged to consult experts for a second opinion before undergoing a biopsy procedure, which is likely to hinder the growth of the market.
The test type segment is categorized into needle breast biopsies and open surgical biopsies. The former is further segmented into fine-needle aspiration, core-needle, and vacuum-assisted core biopsy. The fine-needle aspiration segment is estimated to hold the largest share for the year 2015 whereas the vacuum-assisted core biopsy segment is anticipated to witness a lucrative growth during the study period. The open surgical biopsy industry is sub-segmented into Incisional biopsy and Excisional biopsy.
On the basis of products, the industry is categorized into needles, tables, localization wires, and guidance systems.Additionally, the guidance systems segment of the industry is further categorized on the basis of imaging systems, such as ultrasound, mammography, and magnetic resonance imaging.
Further key findings from the study suggest:
The Asia Pacific region is anticipated to witness the highest growth rate, with a CAGR of around 12.6% during the forecast period. The high frequencies of breast cancer prevailing in women as well as the increase in awareness of cancer screening programs are the factors fueling the market growth.
North America accounts for the largest market share, followed by the European market. The heightened awareness about breast cancer that advocate regular checkups and screening programs along with the demand for accurate and minimally caustic procedures are factors that are responsible for the rapid market growth.
The mammography-guided stereotactic segment is estimated to hold the largest market share followed by the magnetic resonance imaging-guided category. The rise in demand for rapid and precise diagnostic imaging tools in determining the exact location of the tumor or lump in the breast area is one of the major factors driving the growth of this industry
On the basis of test type, the needle-based biopsy segment accounts for the largest share; this is mainly due to the high demand for minimally invasive procedures. On the other hand, the open surgical biopsies have a probability to witness a decline in the market over the next few years due to the relatively high invasiveness and the risks involved with the procedure.
Some major players in this industry include Becton, Dickenson and Company (BD),C.R Bard, Inc., Devicor medical, Inc., and Hologic, Inc., among others.
The test type segment is categorized into needle breast biopsies and open surgical biopsies. The former is further segmented into fine-needle aspiration, core-needle, and vacuum-assisted core biopsy. The fine-needle aspiration segment is estimated to hold the largest share for the year 2015 whereas the vacuum-assisted core biopsy segment is anticipated to witness a lucrative growth during the study period. The open surgical biopsy industry is sub-segmented into Incisional biopsy and Excisional biopsy.
On the basis of products, the industry is categorized into needles, tables, localization wires, and guidance systems.Additionally, the guidance systems segment of the industry is further categorized on the basis of imaging systems, such as ultrasound, mammography, and magnetic resonance imaging.
Further key findings from the study suggest:
The Asia Pacific region is anticipated to witness the highest growth rate, with a CAGR of around 12.6% during the forecast period. The high frequencies of breast cancer prevailing in women as well as the increase in awareness of cancer screening programs are the factors fueling the market growth.
North America accounts for the largest market share, followed by the European market. The heightened awareness about breast cancer that advocate regular checkups and screening programs along with the demand for accurate and minimally caustic procedures are factors that are responsible for the rapid market growth.
The mammography-guided stereotactic segment is estimated to hold the largest market share followed by the magnetic resonance imaging-guided category. The rise in demand for rapid and precise diagnostic imaging tools in determining the exact location of the tumor or lump in the breast area is one of the major factors driving the growth of this industry
On the basis of test type, the needle-based biopsy segment accounts for the largest share; this is mainly due to the high demand for minimally invasive procedures. On the other hand, the open surgical biopsies have a probability to witness a decline in the market over the next few years due to the relatively high invasiveness and the risks involved with the procedure.
Some major players in this industry include Becton, Dickenson and Company (BD),C.R Bard, Inc., Devicor medical, Inc., and Hologic, Inc., among others.
CHAPTER 1. METHODOLOGY AND SCOPE
1.1. Research methodology
1.2. Research scope & assumption
1.3. List of data sources
CHAPTER 2. EXECUTIVE SUMMARY
CHAPTER 3. MARKET SNAPSHOT
CHAPTER 4. MARKET VARIABLES, TRENDS & SCOPE
4.1. Market segmentation
4.2. Market size and growth prospects, 2013 - 2024
4.3. Breast biopsy devices: Market dynamics
4.3.1. Market Driver Analysis
4.3.1.1. Rising prevalence of breast cancer in women
4.3.1.2. Global awareness and cancer screening programs
4.3.1.3. Demand for alternative, less-invasive and accurate procedures
4.3.2. Market Restraints Analysis
4.3.2.1. Awareness of risks associated with breast biopsies lead to expert second opinions
4.4. Key Opportunities Prioritized
4.5. Breast biopsy devices- SWOT analysis, by factor (political, legal, economic, and technological)
4.6. Industry analysis - Porter’s five forces analysis
4.7. Breast biopsy devices: Company market share, 2015
CHAPTER 5. MARKET CATEGORIZATION 1: TEST TYPE ESTIMATES & TREND ANALYSIS
5.1. Breast Biopsy Device Market: Type movement analysis
5.1.1. Needle breast biopsy
5.1.1.1. Fine-needle aspiration
5.1.1.1.1. Market estimates and forecasts, 2013 - 2024 (USD Million)
5.1.1.2. Core-needle aspiration
5.1.1.2.1. Market estimates and forecasts, 2013 - 2024 (USD Million)
5.1.1.3. Vacuum-assisted core biopsy
5.1.1.3.1. Market estimates and forecasts, 2013 - 2024 (USD Million)
5.1.2. Surgical biopsy
5.1.2.1. Incisional breast biopsy
5.1.2.1.1. Market estimates and forecasts, 2013 - 2024 (USD Million)
5.1.2.2. Excisional breast biopsy
5.1.2.2.1. Market estimates and forecasts, 2013 - 2024 (USD Million)
CHAPTER 6. MARKET CATEGORIZATION 2: PRODUCT ESTIMATES & TREND ANALYSIS
6.1. Breast Biopsy Device Market: Product movement analysis
6.1.1. Biopsy needles
6.1.1.1. Market estimates and forecasts, 2013 - 2024 (USD Million)
6.1.2. Biopsy tables
6.1.2.1. Market estimates and forecasts, 2013 - 2024 (USD Million)
6.1.3. Localization wires
6.1.3.1. Market estimates and forecasts, 2013 - 2024 (USD Million)
6.1.4. Guidance systems
6.1.4.1. Market estimates and forecasts, 2013 - 2024 (USD Million)
6.1.5. Others
6.1.5.1. Market estimates and forecasts, 2013 - 2024 (USD Million)
CHAPTER 7. MARKET CATEGORIZATION 3: GUIDANCE TYPE ESTIMATES & TREND ANALYSIS
7.1. Breast Biopsy Device Market: Guidance type movement analysis
7.1.1. Ultrasound-guided
7.1.1.1. Market estimates and forecasts, 2013 - 2024 (USD Million)
7.1.2. Mammography-guided stereotactic
7.1.2.1. Market estimates and forecasts, 2013 - 2024 (USD Million)
7.1.3. Magnetic resonance-guided
7.1.3.1. Market estimates and forecasts, 2013 - 2024 (USD Million)
7.1.4. Others
7.1.4.1. Market estimates and forecasts, 2013 - 2024 (USD Million)
CHAPTER 8. MARKET CATEGORIZATION 4: REGIONAL ESTIMATES & TREND ANALYSIS, BY TEST TYPE, PRODUCT, &GUIDANCE TYPE
8.1. Breast Biopsy Device Market share by region, 2016 & 2024
8.2. North America
8.2.1. U.S.
8.2.1.1. Market estimates and forecasts, by test type, 2013 - 2024 (USD Million)
8.2.1.2. Market estimates and forecasts, by product, 2013 - 2024 (USD Million)
8.2.1.3. Market estimates and forecasts, by guidance type, 2013 - 2024 (USD Million)
8.2.2. Canada
8.2.2.1. Market estimates and forecasts, by test type, 2013 - 2024 (USD Million)
8.2.2.2. Market estimates and forecasts, by product, 2013 - 2024 (USD Million)
8.2.2.3. Market estimates and forecasts, by guidance type, 2013 - 2024 (USD Million)
8.3. Europe
8.3.1. Germany
8.3.1.1. Market estimates and forecasts by test type, 2013 - 2024 (USD Million)
8.3.1.2. Market estimates and forecasts, by product, 2013 - 2024 (USD Million)
8.3.1.3. Market estimates and forecasts, by guidance type, 2013 - 2024 (USD Million)
8.3.2. U.K.
8.3.2.1. Market estimates and forecasts, by test type, 2013 - 2024 (USD Million)
8.3.2.2. Market estimates and forecasts, by product, 2013 - 2024 (USD Million)
8.3.2.3. Market estimates and forecasts, by guidance type, 2013 - 2024 (USD Million)
8.4. Asia Pacific
8.4.1. China
8.4.1.1. Market estimates and forecasts, by test type, 2013 - 2024 (USD Million)
8.4.1.2. Market estimates and forecasts, byproduct, 2013 - 2024 (USD Million)
8.4.1.3. Market estimates and forecasts, by guidance type, 2013 - 2024 (USD Million)
8.4.2. India
8.4.2.1. Market estimates and forecasts, by test type, 2013 - 2024 (USD Million)
8.4.2.2. Market estimates and forecasts, byproduct, 2013 - 2024 (USD Million)
8.4.2.3. Market estimates and forecasts, by guidance type, 2013 - 2024 (USD Million)
8.5. Latin America
8.5.1. Mexico
8.5.1.1. Market estimates and forecasts, by test type, 2013 - 2024 (USD Million)
8.5.1.2. Market estimates and forecasts, by product, 2013 - 2024 (USD Million)
8.5.1.3. Market estimates and forecasts, by guidance type, 2013 - 2024 (USD Million)
8.5.2. Brazil
8.5.2.1. Market estimates and forecasts, by test type, 2013 - 2024 (USD Million)
8.5.2.2. Market estimates and forecasts, by product, 2013 - 2024 (USD Million)
8.5.2.3. Market estimates and forecasts, by guidance type, 2013 - 2024 (USD Million)
8.6. MEA
8.6.1. South Africa
8.6.1.1. Market estimates and forecasts, by test type, 2013 - 2024 (USD Million)
8.6.1.2. Market estimates and forecasts, by product, 2013 - 2024 (USD Million)
8.6.1.3. Market estimates and forecasts, by guidance type, 2013 - 2024 (USD Million)
8.6.1.4. Market estimates and forecasts, by testtype, 2013 - 2024 (USD Million)
CHAPTER 9. COMPETITIVE LANDSCAPE
9.1. Company Profiles
9.1.1. Becton, Dickinson and Company (BD)
9.1.1.1. Company Overview
9.1.1.2. Financial Performance
9.1.1.3. Product Benchmarking
9.1.1.4. Strategic Initiatives
9.1.2. C.R Bard, Inc.
9.1.2.1. Company Overview
9.1.2.2. Financial Performance
9.1.2.3. Product Benchmarking
9.1.2.4. Strategic Initiatives
9.1.3. Devicor Medical Products, Inc.
9.1.3.1. Company Overview
9.1.3.2. Financial Performance
9.1.3.3. Product Benchmarking
9.1.3.4. Strategic Initiatives
9.1.4. Hologic, Inc.
9.1.4.1. Company Overview
9.1.4.2. Financial Performance
9.1.4.3. Product Benchmarking
9.1.4.4. Strategic Initiatives
9.1.5. Stryker International, Inc.
9.1.5.1. Company Overview
9.1.5.2. Financial Performance
9.1.5.3. Product Benchmarking
9.1.5.4. Strategic Initiatives
9.1.6. Argon Medical Devices, Inc.
9.1.6.1. Company Overview
9.1.6.2. Financial Performance
9.1.6.3. Product Benchmarking
9.1.6.4. Strategic Initiatives
9.1.7. Scion Medical Technologies, LLC
9.1.7.1. Company Overview
9.1.7.2. Financial Performance
9.1.7.3. Product Benchmarking
9.1.7.4. Strategic Initiatives
9.1.8. Cook Medical, Inc.
9.1.8.1. Company Overview
9.1.8.2. Financial Performance
9.1.8.3. Product Benchmarking
9.1.8.4. Strategic Initiatives
1.1. Research methodology
1.2. Research scope & assumption
1.3. List of data sources
CHAPTER 2. EXECUTIVE SUMMARY
CHAPTER 3. MARKET SNAPSHOT
CHAPTER 4. MARKET VARIABLES, TRENDS & SCOPE
4.1. Market segmentation
4.2. Market size and growth prospects, 2013 - 2024
4.3. Breast biopsy devices: Market dynamics
4.3.1. Market Driver Analysis
4.3.1.1. Rising prevalence of breast cancer in women
4.3.1.2. Global awareness and cancer screening programs
4.3.1.3. Demand for alternative, less-invasive and accurate procedures
4.3.2. Market Restraints Analysis
4.3.2.1. Awareness of risks associated with breast biopsies lead to expert second opinions
4.4. Key Opportunities Prioritized
4.5. Breast biopsy devices- SWOT analysis, by factor (political, legal, economic, and technological)
4.6. Industry analysis - Porter’s five forces analysis
4.7. Breast biopsy devices: Company market share, 2015
CHAPTER 5. MARKET CATEGORIZATION 1: TEST TYPE ESTIMATES & TREND ANALYSIS
5.1. Breast Biopsy Device Market: Type movement analysis
5.1.1. Needle breast biopsy
5.1.1.1. Fine-needle aspiration
5.1.1.1.1. Market estimates and forecasts, 2013 - 2024 (USD Million)
5.1.1.2. Core-needle aspiration
5.1.1.2.1. Market estimates and forecasts, 2013 - 2024 (USD Million)
5.1.1.3. Vacuum-assisted core biopsy
5.1.1.3.1. Market estimates and forecasts, 2013 - 2024 (USD Million)
5.1.2. Surgical biopsy
5.1.2.1. Incisional breast biopsy
5.1.2.1.1. Market estimates and forecasts, 2013 - 2024 (USD Million)
5.1.2.2. Excisional breast biopsy
5.1.2.2.1. Market estimates and forecasts, 2013 - 2024 (USD Million)
CHAPTER 6. MARKET CATEGORIZATION 2: PRODUCT ESTIMATES & TREND ANALYSIS
6.1. Breast Biopsy Device Market: Product movement analysis
6.1.1. Biopsy needles
6.1.1.1. Market estimates and forecasts, 2013 - 2024 (USD Million)
6.1.2. Biopsy tables
6.1.2.1. Market estimates and forecasts, 2013 - 2024 (USD Million)
6.1.3. Localization wires
6.1.3.1. Market estimates and forecasts, 2013 - 2024 (USD Million)
6.1.4. Guidance systems
6.1.4.1. Market estimates and forecasts, 2013 - 2024 (USD Million)
6.1.5. Others
6.1.5.1. Market estimates and forecasts, 2013 - 2024 (USD Million)
CHAPTER 7. MARKET CATEGORIZATION 3: GUIDANCE TYPE ESTIMATES & TREND ANALYSIS
7.1. Breast Biopsy Device Market: Guidance type movement analysis
7.1.1. Ultrasound-guided
7.1.1.1. Market estimates and forecasts, 2013 - 2024 (USD Million)
7.1.2. Mammography-guided stereotactic
7.1.2.1. Market estimates and forecasts, 2013 - 2024 (USD Million)
7.1.3. Magnetic resonance-guided
7.1.3.1. Market estimates and forecasts, 2013 - 2024 (USD Million)
7.1.4. Others
7.1.4.1. Market estimates and forecasts, 2013 - 2024 (USD Million)
CHAPTER 8. MARKET CATEGORIZATION 4: REGIONAL ESTIMATES & TREND ANALYSIS, BY TEST TYPE, PRODUCT, &GUIDANCE TYPE
8.1. Breast Biopsy Device Market share by region, 2016 & 2024
8.2. North America
8.2.1. U.S.
8.2.1.1. Market estimates and forecasts, by test type, 2013 - 2024 (USD Million)
8.2.1.2. Market estimates and forecasts, by product, 2013 - 2024 (USD Million)
8.2.1.3. Market estimates and forecasts, by guidance type, 2013 - 2024 (USD Million)
8.2.2. Canada
8.2.2.1. Market estimates and forecasts, by test type, 2013 - 2024 (USD Million)
8.2.2.2. Market estimates and forecasts, by product, 2013 - 2024 (USD Million)
8.2.2.3. Market estimates and forecasts, by guidance type, 2013 - 2024 (USD Million)
8.3. Europe
8.3.1. Germany
8.3.1.1. Market estimates and forecasts by test type, 2013 - 2024 (USD Million)
8.3.1.2. Market estimates and forecasts, by product, 2013 - 2024 (USD Million)
8.3.1.3. Market estimates and forecasts, by guidance type, 2013 - 2024 (USD Million)
8.3.2. U.K.
8.3.2.1. Market estimates and forecasts, by test type, 2013 - 2024 (USD Million)
8.3.2.2. Market estimates and forecasts, by product, 2013 - 2024 (USD Million)
8.3.2.3. Market estimates and forecasts, by guidance type, 2013 - 2024 (USD Million)
8.4. Asia Pacific
8.4.1. China
8.4.1.1. Market estimates and forecasts, by test type, 2013 - 2024 (USD Million)
8.4.1.2. Market estimates and forecasts, byproduct, 2013 - 2024 (USD Million)
8.4.1.3. Market estimates and forecasts, by guidance type, 2013 - 2024 (USD Million)
8.4.2. India
8.4.2.1. Market estimates and forecasts, by test type, 2013 - 2024 (USD Million)
8.4.2.2. Market estimates and forecasts, byproduct, 2013 - 2024 (USD Million)
8.4.2.3. Market estimates and forecasts, by guidance type, 2013 - 2024 (USD Million)
8.5. Latin America
8.5.1. Mexico
8.5.1.1. Market estimates and forecasts, by test type, 2013 - 2024 (USD Million)
8.5.1.2. Market estimates and forecasts, by product, 2013 - 2024 (USD Million)
8.5.1.3. Market estimates and forecasts, by guidance type, 2013 - 2024 (USD Million)
8.5.2. Brazil
8.5.2.1. Market estimates and forecasts, by test type, 2013 - 2024 (USD Million)
8.5.2.2. Market estimates and forecasts, by product, 2013 - 2024 (USD Million)
8.5.2.3. Market estimates and forecasts, by guidance type, 2013 - 2024 (USD Million)
8.6. MEA
8.6.1. South Africa
8.6.1.1. Market estimates and forecasts, by test type, 2013 - 2024 (USD Million)
8.6.1.2. Market estimates and forecasts, by product, 2013 - 2024 (USD Million)
8.6.1.3. Market estimates and forecasts, by guidance type, 2013 - 2024 (USD Million)
8.6.1.4. Market estimates and forecasts, by testtype, 2013 - 2024 (USD Million)
CHAPTER 9. COMPETITIVE LANDSCAPE
9.1. Company Profiles
9.1.1. Becton, Dickinson and Company (BD)
9.1.1.1. Company Overview
9.1.1.2. Financial Performance
9.1.1.3. Product Benchmarking
9.1.1.4. Strategic Initiatives
9.1.2. C.R Bard, Inc.
9.1.2.1. Company Overview
9.1.2.2. Financial Performance
9.1.2.3. Product Benchmarking
9.1.2.4. Strategic Initiatives
9.1.3. Devicor Medical Products, Inc.
9.1.3.1. Company Overview
9.1.3.2. Financial Performance
9.1.3.3. Product Benchmarking
9.1.3.4. Strategic Initiatives
9.1.4. Hologic, Inc.
9.1.4.1. Company Overview
9.1.4.2. Financial Performance
9.1.4.3. Product Benchmarking
9.1.4.4. Strategic Initiatives
9.1.5. Stryker International, Inc.
9.1.5.1. Company Overview
9.1.5.2. Financial Performance
9.1.5.3. Product Benchmarking
9.1.5.4. Strategic Initiatives
9.1.6. Argon Medical Devices, Inc.
9.1.6.1. Company Overview
9.1.6.2. Financial Performance
9.1.6.3. Product Benchmarking
9.1.6.4. Strategic Initiatives
9.1.7. Scion Medical Technologies, LLC
9.1.7.1. Company Overview
9.1.7.2. Financial Performance
9.1.7.3. Product Benchmarking
9.1.7.4. Strategic Initiatives
9.1.8. Cook Medical, Inc.
9.1.8.1. Company Overview
9.1.8.2. Financial Performance
9.1.8.3. Product Benchmarking
9.1.8.4. Strategic Initiatives
LIST OF TABLES
1. North America Breast Biopsy Device Market revenue, bytes type, 2013 - 2024 (USD Million)
2. North America Breast Biopsy Device Market revenue, by product, 2013 - 2024 (USD Million)
3. North America Breast Biopsy Device Market revenue, by guidance, 2013 - 2024 (USD Million)
4. U.S. Breast Biopsy Device Market revenue, by test type, 2013 - 2024 (USD Million)
5. U.S. Breast Biopsy Device Market revenue, byproduct, 2016 - 2024 (USD Million)
6. U.S. Breast Biopsy Device Market revenue, by guidance type, 2016 - 2024 (USD Million)
7. Canada Breast Biopsy Device Market revenue, by test type, 2016 - 2024 (USD Million)
8. Canada Breast Biopsy Device Market revenue, by product, 2016 - 2024 (USD Million)
9. Canada Breast Biopsy Device Market revenue, by guidance type, 2016 - 2024 (USD Million)
10. Europe Breast Biopsy Device Market revenue, by test type, 2016 - 2024 (USD Million)
11. Europe Breast Biopsy Device Market revenue, by product, 2016 - 2024 (USD Million)
12. Europe Breast Biopsy Device Market revenue, by guidance type, 2016 - 2024 (USD Million)
13. Germany Breast Biopsy Device Market revenue, by test type, 2016 - 2024 (USD Million)
14. Germany Breast Biopsy Device Market revenue, by product, 2016 - 2024 (USD Million)
15. Germany Breast Biopsy Device Market revenue, by guidance type, 2016 - 2024 (USD Million)
16. UK Breast Biopsy Device Market revenue, by test type, 2013 - 2024 (USD Million)
17. UK Breast Biopsy Device Market revenue, by product, 2013 - 2024 (USD Million)
18. UK Breast Biopsy Device Market revenue, by guidance type, 2013 - 2024 (USD Million)
19. Asia Pacific Breast Biopsy Device Market revenue, by test type, 2013 - 2024 (USD Million)
20. Asia Pacific Breast Biopsy Device Market revenue, byproduct, 2013 - 2024 (USD Million)
21. Asia Pacific Breast Biopsy Device Market revenue, by guidance type, 2013 - 2024 (USD Million)
22. China Breast Biopsy Device Market revenue, bytes type, 2013 - 2024 (USD Million)
23. China Breast Biopsy Device Market revenue, by product, 2013 - 2024 (USD Million)
24. China Breast Biopsy Device Market revenue, by guidance type, 2013 - 2024 (USD Million)
25. India Breast Biopsy Device Market revenue, by test type, 2013 - 2024 (USD Million)
26. India Breast Biopsy Device Market revenue, by product, 2013 - 2024 (USD Million)
27. India Breast Biopsy Device Market revenue, by guidance type, 2013 - 2024 (USD Million)
28. Latin America Breast Biopsy Device Market revenue, by test type, 2013 - 2024 (USD Million)
29. Latin America Breast Biopsy Device Market revenue, by product, 2013 - 2024 (USD Million)
30. Latin America Breast Biopsy Device Market revenue, by guidance type, 2013 - 2024(USD Million)
31. Brazil Breast Biopsy Device Market revenue, by test type, 2013 - 2024 (USD Million)
32. Brazil Breast Biopsy Device Market revenue, by product, 2013 - 2024 (USD Million)
33. Brazil Breast Biopsy Device Market revenue, by guidance type, 2013 - 2024 (USD Million)
34. Mexico Breast Biopsy Device Market revenue, by test type, 2013 - 2024 (USD Million)
35. Mexico Breast Biopsy Device Market revenue, by product, 2013 - 2024 (USD Million)
36. Mexico Breast Biopsy Device Market revenue, by guidance type, 2013 - 2024 (USD Million)
37. MEA Breast Biopsy Device Market revenue, by test type, 2013 - 2024 (USD Million)
38. MEA Breast Biopsy Device Market revenue, by product, 2013 - 2024 (USD Million)
39. MEA Breast Biopsy Device Market revenue, by guidance type, 2013 - 2024 (USD Million)
40. South Africa breast devices biopsy market revenue, by test type, 2013 - 2024 (USD Million)
41. South Africa breast devices biopsy market revenue, by product, 2013 - 2024 (USD Million)
42. South Africa breast devices biopsy market revenue, by guidance type, 2013 - 2024 (USD Million)
1. North America Breast Biopsy Device Market revenue, bytes type, 2013 - 2024 (USD Million)
2. North America Breast Biopsy Device Market revenue, by product, 2013 - 2024 (USD Million)
3. North America Breast Biopsy Device Market revenue, by guidance, 2013 - 2024 (USD Million)
4. U.S. Breast Biopsy Device Market revenue, by test type, 2013 - 2024 (USD Million)
5. U.S. Breast Biopsy Device Market revenue, byproduct, 2016 - 2024 (USD Million)
6. U.S. Breast Biopsy Device Market revenue, by guidance type, 2016 - 2024 (USD Million)
7. Canada Breast Biopsy Device Market revenue, by test type, 2016 - 2024 (USD Million)
8. Canada Breast Biopsy Device Market revenue, by product, 2016 - 2024 (USD Million)
9. Canada Breast Biopsy Device Market revenue, by guidance type, 2016 - 2024 (USD Million)
10. Europe Breast Biopsy Device Market revenue, by test type, 2016 - 2024 (USD Million)
11. Europe Breast Biopsy Device Market revenue, by product, 2016 - 2024 (USD Million)
12. Europe Breast Biopsy Device Market revenue, by guidance type, 2016 - 2024 (USD Million)
13. Germany Breast Biopsy Device Market revenue, by test type, 2016 - 2024 (USD Million)
14. Germany Breast Biopsy Device Market revenue, by product, 2016 - 2024 (USD Million)
15. Germany Breast Biopsy Device Market revenue, by guidance type, 2016 - 2024 (USD Million)
16. UK Breast Biopsy Device Market revenue, by test type, 2013 - 2024 (USD Million)
17. UK Breast Biopsy Device Market revenue, by product, 2013 - 2024 (USD Million)
18. UK Breast Biopsy Device Market revenue, by guidance type, 2013 - 2024 (USD Million)
19. Asia Pacific Breast Biopsy Device Market revenue, by test type, 2013 - 2024 (USD Million)
20. Asia Pacific Breast Biopsy Device Market revenue, byproduct, 2013 - 2024 (USD Million)
21. Asia Pacific Breast Biopsy Device Market revenue, by guidance type, 2013 - 2024 (USD Million)
22. China Breast Biopsy Device Market revenue, bytes type, 2013 - 2024 (USD Million)
23. China Breast Biopsy Device Market revenue, by product, 2013 - 2024 (USD Million)
24. China Breast Biopsy Device Market revenue, by guidance type, 2013 - 2024 (USD Million)
25. India Breast Biopsy Device Market revenue, by test type, 2013 - 2024 (USD Million)
26. India Breast Biopsy Device Market revenue, by product, 2013 - 2024 (USD Million)
27. India Breast Biopsy Device Market revenue, by guidance type, 2013 - 2024 (USD Million)
28. Latin America Breast Biopsy Device Market revenue, by test type, 2013 - 2024 (USD Million)
29. Latin America Breast Biopsy Device Market revenue, by product, 2013 - 2024 (USD Million)
30. Latin America Breast Biopsy Device Market revenue, by guidance type, 2013 - 2024(USD Million)
31. Brazil Breast Biopsy Device Market revenue, by test type, 2013 - 2024 (USD Million)
32. Brazil Breast Biopsy Device Market revenue, by product, 2013 - 2024 (USD Million)
33. Brazil Breast Biopsy Device Market revenue, by guidance type, 2013 - 2024 (USD Million)
34. Mexico Breast Biopsy Device Market revenue, by test type, 2013 - 2024 (USD Million)
35. Mexico Breast Biopsy Device Market revenue, by product, 2013 - 2024 (USD Million)
36. Mexico Breast Biopsy Device Market revenue, by guidance type, 2013 - 2024 (USD Million)
37. MEA Breast Biopsy Device Market revenue, by test type, 2013 - 2024 (USD Million)
38. MEA Breast Biopsy Device Market revenue, by product, 2013 - 2024 (USD Million)
39. MEA Breast Biopsy Device Market revenue, by guidance type, 2013 - 2024 (USD Million)
40. South Africa breast devices biopsy market revenue, by test type, 2013 - 2024 (USD Million)
41. South Africa breast devices biopsy market revenue, by product, 2013 - 2024 (USD Million)
42. South Africa breast devices biopsy market revenue, by guidance type, 2013 - 2024 (USD Million)
